ICU Medical (ICUI)
(Delayed Data from NSDQ)
$176.74 USD
-4.53 (-2.50%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $176.84 +0.10 (0.06%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for ICU Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 255 | 213 | 567 | 411 | 293 |
Receivables | 162 | 222 | 106 | 124 | 202 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 709 | 696 | 290 | 315 | 338 |
Other Current Assets | 96 | 104 | 66 | 71 | 50 |
Total Current Assets | 1,221 | 1,235 | 1,030 | 921 | 882 |
Net Property & Equipment | 613 | 636 | 468 | 467 | 456 |
Investments & Advances | 0 | 1 | 5 | 13 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 37 | 31 | 43 | 31 | 28 |
Intangibles | 2,343 | 2,432 | 232 | 230 | 243 |
Deposits & Other Assets | 94 | 105 | 64 | 55 | 49 |
Total Assets | 4,378 | 4,516 | 1,881 | 1,764 | 1,692 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 150 | 216 | 81 | 72 | 129 |
Current Portion Long-Term Debt | 51 | 30 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 268 | 243 | 118 | 97 | 118 |
Income Taxes Payable | 8 | 6 | 1 | 0 | 2 |
Other Current Liabilities | 5 | 0 | 0 | 26 | 0 |
Total Current Liabilities | 482 | 495 | 201 | 195 | 248 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 56 | 126 | 1 | 2 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,578 | 1,624 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 140 | 181 | 62 | 64 | 65 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,255 | 2,426 | 265 | 261 | 315 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 1,366 | 1,331 | 721 | 693 | 669 |
Retained Earnings | 808 | 838 | 912 | 809 | 722 |
Other Equity | -53 | -81 | -19 | -2 | -15 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 2,123 | 2,090 | 1,616 | 1,502 | 1,377 |
Total Liabilities & Shareholder's Equity | 4,378 | 4,516 | 1,881 | 1,764 | 1,692 |
Total Common Equity | 2,123 | 2,090 | 1,616 | 1,502 | 1,377 |
Shares Outstanding | 24.14 | 23.98 | 21.20 | 20.90 | 20.60 |
Book Value Per Share | 87.96 | 87.15 | 76.23 | 71.88 | 66.86 |
Fiscal Year End for ICU Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 303 | 251 | 255 | 199 | 198 |
Receivables | 152 | 145 | 162 | 162 | 162 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 683 | 693 | 709 | 760 | 775 |
Other Current Assets | 99 | 98 | 96 | 99 | 110 |
Total Current Assets | 1,236 | 1,188 | 1,221 | 1,219 | 1,245 |
Net Property & Equipment | 594 | 603 | 613 | 609 | 617 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 39 | 40 | 37 | 31 | 31 |
Intangibles | 2,257 | 2,296 | 2,343 | 2,336 | 2,394 |
Deposits & Other Assets | 95 | 97 | 94 | 108 | 100 |
Total Assets | 4,287 | 4,288 | 4,378 | 4,377 | 4,463 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 156 | 152 | 150 | 149 | 167 |
Current Portion Long-Term Debt | 51 | 51 | 51 | 46 | 40 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 300 | 248 | 268 | 251 | 255 |
Income Taxes Payable | 4 | 2 | 8 | 11 | 20 |
Other Current Liabilities | 2 | 2 | 5 | 6 | 2 |
Total Current Liabilities | 512 | 455 | 482 | 464 | 484 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 54 | 56 | 56 | 78 | 90 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,555 | 1,566 | 1,578 | 1,589 | 1,601 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 128 | 140 | 147 | 174 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,249 | 2,221 | 2,255 | 2,279 | 2,348 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 1,381 | 1,371 | 1,366 | 1,356 | 1,345 |
Retained Earnings | 747 | 768 | 808 | 825 | 818 |
Other Equity | -92 | -70 | -53 | -85 | -49 |
Treasury Stock | 1 | 5 | 0 | 1 | 2 |
Total Shareholder's Equity | 2,038 | 2,068 | 2,123 | 2,098 | 2,115 |
Total Liabilities & Shareholder's Equity | 4,287 | 4,288 | 4,378 | 4,377 | 4,463 |
Total Common Equity | 2,038 | 2,068 | 2,123 | 2,098 | 2,115 |
Shares Outstanding | 24.37 | 24.37 | 24.10 | 24.10 | 24.00 |
Book Value Per Share | 83.62 | 84.85 | 88.11 | 87.07 | 88.12 |